Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Nonsteroidal inhibitors of steroid C17,20-lyase developed at Yamanouchi

Sep. 25, 1997

Novartis prepares protein tyrosine kinase inhibitors

Sep. 25, 1997

Lisofylline collaboration expanded to include AML

Sep. 24, 1997

p53 phase II trial for head and neck cancer

Sep. 24, 1997

Micrologix Biotech and BCCA expand research for anticancer agents

Sep. 24, 1997

BioChem Therapeutic synthesizes antiangiogenic fumagillin analogues

Sep. 24, 1997

More new taxoids from Rhone-Poulenc Rorer

Sep. 24, 1997

Protein farnesyltransferase inhibitors prepared at Schering-Plough

Sep. 24, 1997

NCI to fund clinical trials of Pharmacyclics' Gd-Tex

Sep. 22, 1997

FDA panel recommends approval of Paxene

Sep. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...